Next Quarterly Earnings
Thursday, August 20, 2026
CW 34
Pre-Market
In 45 days
Jiangsu Hengrui Medicine is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and distribution of innovative medicines. The company focuses on oncology, autoimmune diseases, pain management, and metabolic disorders to improve global patient care. It drives biopharmaceutical innovation forward.